Filing Details
- Accession Number:
- 0001209191-20-048927
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-01 16:37:38
- Reporting Period:
- 2020-08-28
- Accepted Time:
- 2020-09-01 16:37:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679082 | Myovant Sciences Ltd. | MYOV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1276700 | Frank Karbe | C/O Myovant Sciences Inc. 2000 Sierra Point Parkway, 9Th Floor Brisbane CA 94005 | Principal Fin'l & Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-08-28 | 3,650 | $5.11 | 167,120 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2020-08-28 | 3,650 | $20.04 | 163,470 | No | 4 | S | Direct | |
| Common Shares | Acquisiton | 2020-08-31 | 21,150 | $5.11 | 184,620 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2020-08-31 | 21,150 | $20.01 | 163,470 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-08-28 | 3,650 | $0.00 | 3,650 | $5.11 |
| Common Shares | Stock Option (Right to Buy) | Disposition | 2020-08-31 | 21,150 | $0.00 | 21,150 | $5.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 221,294 | 2026-09-20 | No | 4 | M | Direct | |
| 200,144 | 2026-09-20 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan.
- The shares were sold at prices ranging from $20.00 to $20.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $20.00 to $20.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
